In mice and cells deficient in type I IFN receptor R1 (IFNR1), ISG15 production decreases significantly following treatment with lipopolysaccharide (LPS) from Gram-negative bacteria or viral infections [111,112]. Here, ISG15 is linked to viral infectious disease.